Jun Shirakawa

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Venues

Journal of diabetes investigation

Diabetes therapy : research, treatment and education of diabetes and related disorders

International journal of molecular sciences

Journal of medical case reports

Yokohama City University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Yokohama City University

Japan

Associate Professor :: Endocrinology and Metabolism

Publications

Sakiko Terui, Mari Igari, Takahiro Tsuno, Tomoko Okuyama, Ryota Inoue, Mayu Kyohara, Yasuo Terauchi, Jun Shirakawa
Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (5) (2024)
Sakiko Terui, Mari Igari, Takahiro Tsuno, Tomoko Okuyama, Ryota Inoue, Mayu Kyohara, Yasuo Terauchi, Jun Shirakawa
Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
Sakiko Terui, Mari Igari, Takahiro Tsuno, Tomoko Okuyama, Ryota Inoue, Mayu Kyohara, Yasuo Terauchi, Jun Shirakawa
Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (5) (2024)
Sakiko Terui, Mari Igari, Takahiro Tsuno, Tomoko Okuyama, Ryota Inoue, Mayu Kyohara, Yasuo Terauchi, Jun Shirakawa
Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (5) (2024)
Kuniyuki Nishiyama, Masato Ono, Takahiro Tsuno, Ryota Inoue, Ayako Fukunaka, Tomoko Okuyama, Mayu Kyohara, Yu Togashi, Setsuko Fukushima, Takuto Atsumi, Aoi Sato, Asuka Tsurumoto, Chisato Sakai, Yoshio Fujitani, Yasuo Terauchi, Shuichi Ito, Jun Shirakawa
Protective effects of imeglimin and metformin combination therapy on β-cells in db/db male mice. Endocrinology (2023)
Masanori Arai, Takahiro Tsuno, Hiromi Konishi, Kuniyuki Nishiyama, Yasuo Terauchi, Ryota Inoue, Jun Shirakawa
A Disproportionality Analysis of the Adverse Effect Profiles of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Using the Japanese Adverse Drug Event Report Database. Thyroid : official journal of the American Thyroid Association (2023)
Sohyun Moon, Lamyaa Alsarkhi, Tai-Tu Lin, Ryota Inoue, Azeddine Tahiri, Cecilia Colson, Weikang Cai, Jun Shirakawa, Wei-Jun Qian, Jerry Yingtao Zhao, Abdelfattah El Ouaamari
Transcriptome and secretome profiling of sensory neurons reveals sex differences in pathways relevant to insulin sensing and insulin secretion. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (10) (2023)
Jun Shirakawa
Signaling pathways that regulate adaptive β-cell proliferation for the treatment of diabetes. Journal of diabetes investigation (2023)
Hisashi Hirano, Jun Shirakawa
Recent developments in Phos-tag electrophoresis for the analysis of phosphoproteins in proteomics. Expert review of proteomics 19 (2) (2022)
Mayu Kyohara, Daisuke Miyashita, Ryota Inoue, Kuniyuki Nishiyama, Takahiro Tsuno, Tomoko Okuyama, Yu Togashi, Yasuo Terauchi, Jun Shirakawa
Association between circulating SerpinB1 levels and insulin sensitivity in Japanese with type 2 diabetes: A single-center, cross-sectional, observational study. PloS one 17 (11) (2022)
Yu Togashi, Daisuke Miyashita, Takahiro Tsuno, Ryota Inoue, Tomoko Okuyama, Mayu Kyohara, Kuniyuki Nishiyama, Masanori Arai, Kenta Kanematsu, Soichiro Kanataki, Yasuo Terauchi, Jun Shirakawa
Abdominal aortic calcification is associated with Fibrosis-4 index and low body mass index in type 2 diabetes patients: A retrospective cross-sectional study. Journal of diabetes investigation 13 (11) (2022)
Ryota Inoue, Kuniyuki Nishiyama, Jinghe Li, Daisuke Miyashita, Masato Ono, Yasuo Terauchi, Jun Shirakawa
The Feasibility and Applicability of Stem Cell Therapy for the Cure of Type 1 Diabetes. Cells 10 (7) (2021)
Masanori Hasebe, Jun Shirakawa, Daisuke Miyashita, Rieko Kunishita, Mayu Kyohara, Tomoko Okuyama, Yu Togashi, Yasuo Terauchi
Asymptomatic meningitis diagnosed by positron emission tomography in a patient with syndrome of inappropriate antidiuretic hormone secretion: a case report. Journal of medical case reports 15 (1) (2021)
Taichi Minami, Jun Shirakawa, Hiroko Hiiragi, Taku Yamada, Youichi Suzuki, Shinitiro Shirabe, Hajime Maeda, Yasuo Terauchi
Validity and reliability of the Japanese version of the diabetes knowledge test among in-patients with type 2 diabetes. Journal of diabetes investigation (2021)
Tomoko Okuyama, Mayu Kyohara, Yasuo Terauchi, Jun Shirakawa
The Roles of the IGF Axis in the Regulation of the Metabolism: Interaction and Difference between Insulin Receptor Signaling and IGF-I Receptor Signaling. International journal of molecular sciences 22 (13) (2021)
Jun Shirakawa
Translational research on human pancreatic β-cell mass expansion for the treatment of diabetes. Diabetology international 12 (4) (2021)
Sakiko Terui, Ryoichi Akamatsu, Masanori Arai, Ryota Inoue, Tomoko Okuyama, Mayu Kyohara, Jinghe Li, Takahiro Tsuno, Daisuke Miyashita, Yu Togashi, Yasuo Terauchi, Jun Shirakawa
Immediate Glucose-Lowering Effect After the First Administration of Dulaglutide: A Retrospective, Single-Center, Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 12 (11) (2021)
Jun Shirakawa
Pancreatic β-cell fate in subjects with COVID-19. Journal of diabetes investigation (2021)
Mayu Kyohara, Jun Shirakawa, Tomoko Okuyama, Yu Togashi, Ryota Inoue, Jinghe Li, Daisuke Miyashita, Yasuo Terauchi
Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects. Diabetology & metabolic syndrome 12 (2020)
Tomoko Okuyama, Jun Shirakawa, Kazuki Tajima, Yoko Ino, Heidrun Vethe, Yu Togashi, Mayu Kyohara, Ryota Inoue, Daisuke Miyashita, Jinghe Li, Nozomi Goto, Taiga Ichikawa, Shingo Yamasaki, Haruka Ohnuma, Rie Takayanagi, Yayoi Kimura, Hisashi Hirano, Yasuo Terauchi
Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor. International journal of molecular sciences 21 (21) (2020)
Jun Shirakawa, Yasuo Terauchi
Potential linkage between dipeptidyl peptidase-4 inhibitor use and the risk of pancreatitis/pancreatic cancer. Journal of diabetes investigation 11 (4) (2020)
Hao Wang, Kouichi Mizuno, Noriko Takahashi, Eri Kobayashi, Jun Shirakawa, Yasuo Terauchi, Haruo Kasai, Katsuhide Okunishi, Tetsuro Izumi
Melanophilin Accelerates Insulin Granule Fusion without Predocking to the Plasma Membrane. Diabetes 69 (12) (2020)
Jun Shirakawa, Kazuki Tajima, Tomoko Okuyama, Mayu Kyohara, Yu Togashi, Dario F De Jesus, Giorgio Basile, Tatsuya Kin, A M James Shapiro, Rohit N Kulkarni, Yasuo Terauchi
Luseogliflozin increases beta cell proliferation through humoral factors that activate an insulin receptor- and IGF-1 receptor-independent pathway. Diabetologia 63 (3) (2020)
Masanori Arai, Jun Shirakawa, Hiromi Konishi, Naoko Sagawa, Yasuo Terauchi
Bullous Pemphigoid and Dipeptidyl Peptidase 4 Inhibitors: A Disproportionality Analysis Based on the Japanese Adverse Drug Event Report Database. Diabetes care 41 (9) (2018)

Jun Shirakawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jun Shirakawa